prednisolone has been researched along with Respiratory Sounds in 59 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Respiratory Sounds: Noises, normal and abnormal, heard on auscultation over any part of the RESPIRATORY TRACT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to evaluate the effect of 8 months of treatment with itraconazole on airway wall thickness in patients with severe persistent asthma." | 9.69 | Itraconazole Improved Bronchial Wall Thickness in Severe Persistent Asthma: A Double-blind Placebo-controlled Randomized Clinical Trial. ( Aligolighasemabadi, F; Ghaffari, S; Hashemi Attar, A; Mirsadraee, M; Naghibi, S; Sadeghdoust, M; Sarafraz Yazdi, M, 2023) |
| "Overall, prednisolone did not affect the time to initiation of asthma control medication when compared to placebo." | 9.24 | Prednisolone for the first rhinovirus-induced wheezing and 4-year asthma risk: A randomized trial. ( Camargo, CA; Gern, J; Jartti, T; Koistinen, A; Lukkarinen, M; Ruuskanen, O; Turunen, R; Vahlberg, T; Vuorinen, T, 2017) |
| " Prednisolone decreased the probability of recurrent wheezing in children with eczema (0." | 9.12 | Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. ( Jartti, T; Lehtinen, P; Ruohola, A; Ruuskanen, O; Vanto, T; Vuorinen, T, 2007) |
| "To estimate the effect of prednisolone on 5-lipoxygenase activity in eosinophils obtained from asthmatic patients, cytosolic levels of 5-H(P)ETE and Ca2+ were measured in the eosinophils which were exposed to prednisolone in vitro and in vivo." | 9.08 | Prednisolone inhibits synthesis of 5-H(P)ETE in eosinophils from asthmatic patients during a wheezing attack but not during remission. ( Fukumura, M; Koide, K; Machida, M; Shindo, K, 1998) |
| "To determine the duration of stridor at rest (SAR) after the administration of oral prednisolone (1 mg/kg) to children admitted to hospital with croup from the ED." | 7.72 | How long does stridor at rest persist in croup after the administration of oral prednisolone? ( Kelly, AM; Parker, R; Powell, CV, 2004) |
| "The purpose of this study was to evaluate the effect of 8 months of treatment with itraconazole on airway wall thickness in patients with severe persistent asthma." | 5.69 | Itraconazole Improved Bronchial Wall Thickness in Severe Persistent Asthma: A Double-blind Placebo-controlled Randomized Clinical Trial. ( Aligolighasemabadi, F; Ghaffari, S; Hashemi Attar, A; Mirsadraee, M; Naghibi, S; Sadeghdoust, M; Sarafraz Yazdi, M, 2023) |
| "Overall, prednisolone did not affect the time to initiation of asthma control medication when compared to placebo." | 5.24 | Prednisolone for the first rhinovirus-induced wheezing and 4-year asthma risk: A randomized trial. ( Camargo, CA; Gern, J; Jartti, T; Koistinen, A; Lukkarinen, M; Ruuskanen, O; Turunen, R; Vahlberg, T; Vuorinen, T, 2017) |
| " Prednisolone decreased the probability of recurrent wheezing in children with eczema (0." | 5.12 | Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. ( Jartti, T; Lehtinen, P; Ruohola, A; Ruuskanen, O; Vanto, T; Vuorinen, T, 2007) |
| "To estimate the effect of prednisolone on 5-lipoxygenase activity in eosinophils obtained from asthmatic patients, cytosolic levels of 5-H(P)ETE and Ca2+ were measured in the eosinophils which were exposed to prednisolone in vitro and in vivo." | 5.08 | Prednisolone inhibits synthesis of 5-H(P)ETE in eosinophils from asthmatic patients during a wheezing attack but not during remission. ( Fukumura, M; Koide, K; Machida, M; Shindo, K, 1998) |
| "To determine the duration of stridor at rest (SAR) after the administration of oral prednisolone (1 mg/kg) to children admitted to hospital with croup from the ED." | 3.72 | How long does stridor at rest persist in croup after the administration of oral prednisolone? ( Kelly, AM; Parker, R; Powell, CV, 2004) |
| "Rhinovirus-induced wheezing is an important risk factor for recurrent wheezing." | 2.80 | Short- and long-term efficacy of prednisolone for first acute rhinovirus-induced wheezing episode. ( Camargo, CA; Gern, J; Jartti, T; Lehtinen, P; Nieminen, R; Ruuskanen, O; Vahlberg, T; Vuorinen, T, 2015) |
| "Acute disseminated encephalomyelitis is typically a monophasic, postinfectious, demyelinating disease that presents most often with encephalopathy and acute or subacute, multifocal neurologic deficits." | 2.45 | A child with difficulty swallowing. ( Abramo, TJ; Arnold, DH; Pittard, A, 2009) |
| "Recurrent wheezing is common in preschool-aged children, with 1 in 3 children experiencing at least 1 acute wheezing illness before the age of 3 years." | 2.45 | Recurrent wheezing illness in preschool-aged children: assessment and management in primary care practice. ( Bloomberg, GR, 2009) |
| "Prednisolone, a routine treatment, is intolerable in almost one-third of children, requiring repeated dosing, which may prolong length of stay (LOS)." | 1.91 | Reducing oral steroid intolerability and drug costs for acute wheezers: A retrospective evaluation of a clinical management algorithm in a Pediatric Emergency Department. ( Bartholome, B; Davison, G; Kennedy, B; McCann, J; McDonald, R; Mullen, S; O'Neill, V; Ruddell, J; Shields, MD; Steen, H; Trouton, M, 2023) |
| "Laryngeal involvement resulting in stridor has been reported in four other cases previously, with three requiring tracheostomy." | 1.48 | Long-term control of laryngeal plasma cell mucositis with systemic immunosuppression. ( Hee, G; Lucas, M; McLean-Tooke, A; Triplett, J, 2018) |
| "Shrinking lung syndrome is characterized by pulmonary compromise secondary to unilateral or bilateral paralysis of the diaphragm." | 1.37 | Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome. ( Brost, BC; DeStephano, CC; Meena, M; Watson, WJ, 2011) |
| "Eight years before presentation, bronchial asthma was diagnosed and the patient received inhaled corticosteroids plus antiasthmatic agents (a long-acting inhaled beta2-agonist, leukotriene modifiers, and theophylline)." | 1.36 | A patient with bronchial asthma in whom eosinophilic bronchitis and bronchiolitis developed during treatment. ( Fukuda, T; Fukushima, F; Fukushima, Y; Hirata, H; Ishii, Y; Kamiya, K; Tatewaki, M, 2010) |
| "However, coexisting bacterial lower respiratory tract infections that induce systemic inflammatory response are seldom detected." | 1.33 | Bacterial coinfections in children with viral wheezing. ( Jartti, T; Lehtinen, P; Leinonen, M; Peltola, V; Ruohola, A; Ruuskanen, O; Virkki, R; Vuorinen, T, 2006) |
| "Dyspnea, cough, inspiratory crackles, and squeaks were the most common symptoms and signs." | 1.30 | Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. ( Cordier, JF; Cottin, V; Donsbeck, AV; Loire, R; Revel, D, 1998) |
| "Prednisolone alone was the most effective therapy, although avoidance of putative aeroallergens and antibacterial therapy was effective in some." | 1.29 | Feline asthma syndrome: a retrospective study of the clinical presentation in 29 cats. ( Corcoran, BM; Foster, DJ; Fuentes, VL, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.39) | 18.7374 |
| 1990's | 6 (10.17) | 18.2507 |
| 2000's | 24 (40.68) | 29.6817 |
| 2010's | 20 (33.90) | 24.3611 |
| 2020's | 7 (11.86) | 2.80 |
| Authors | Studies |
|---|---|
| Erkkola, RA | 1 |
| Virta, LJ | 1 |
| Vahlberg, T | 4 |
| Jartti, T | 11 |
| Davison, G | 1 |
| Ruddell, J | 1 |
| Trouton, M | 1 |
| McDonald, R | 1 |
| Kennedy, B | 1 |
| O'Neill, V | 1 |
| McCann, J | 1 |
| Bartholome, B | 1 |
| Steen, H | 1 |
| Shields, MD | 1 |
| Mullen, S | 1 |
| Aligolighasemabadi, F | 1 |
| Mirsadraee, M | 1 |
| Sadeghdoust, M | 1 |
| Ghaffari, S | 1 |
| Sarafraz Yazdi, M | 1 |
| Naghibi, S | 1 |
| Hashemi Attar, A | 1 |
| Bush, A | 3 |
| Itagane, M | 1 |
| Yano, H | 1 |
| Kishaba, T | 1 |
| Kinjo, M | 1 |
| Wallace, A | 1 |
| Sinclair, O | 1 |
| Shepherd, M | 1 |
| Neutze, J | 1 |
| Trenholme, A | 1 |
| Tan, E | 1 |
| Brabyn, C | 1 |
| Bonisch, M | 1 |
| Grey, N | 1 |
| Johnson, DW | 1 |
| McNamara, D | 1 |
| Thompson, JMD | 1 |
| Asher, I | 1 |
| Dalziel, SR | 1 |
| Hurme, P | 1 |
| Homil, K | 1 |
| Lehtinen, P | 8 |
| Turunen, R | 2 |
| Vuorinen, T | 10 |
| Camargo, CA | 3 |
| Gern, JE | 2 |
| Koistinen, A | 1 |
| Lukkarinen, M | 2 |
| Gern, J | 2 |
| Ruuskanen, O | 9 |
| Foster, SJ | 1 |
| Cooper, MN | 1 |
| Oosterhof, S | 1 |
| Borland, ML | 1 |
| Triplett, J | 1 |
| Hee, G | 1 |
| McLean-Tooke, A | 1 |
| Lucas, M | 1 |
| Beigelman, A | 2 |
| Bacharier, LB | 2 |
| Volk, AS | 1 |
| Marton, SA | 1 |
| Richardson, BS | 1 |
| Rauda, L | 1 |
| Schwarzwald, HL | 1 |
| Naik, NM | 1 |
| Grigg, J | 3 |
| Saglani, S | 1 |
| Tagarro, A | 1 |
| Pérez, L | 1 |
| Quintero, VM | 1 |
| Cañete, A | 1 |
| Nieminen, R | 1 |
| Teague, WG | 1 |
| Ambroggio, L | 1 |
| Test, M | 1 |
| Metlay, JP | 1 |
| Graf, TR | 1 |
| Blosky, MA | 1 |
| Macaluso, M | 1 |
| Shah, SS | 1 |
| Taylor, FJ | 1 |
| Li, G | 1 |
| Almossawi, O | 1 |
| Dulfeker, H | 1 |
| Jones, V | 1 |
| Ruiz, GC | 1 |
| Benchekroun, G | 1 |
| Jane Wood, E | 1 |
| Panickar, J | 1 |
| Lakhanpaul, M | 1 |
| Lambert, PC | 2 |
| Kenia, P | 1 |
| Stephenson, T | 1 |
| Smyth, A | 1 |
| Koumbourlis, AC | 1 |
| Mroueh, S | 1 |
| Weinberger, M | 2 |
| Walter, AW | 1 |
| Pittard, A | 1 |
| Abramo, TJ | 1 |
| Arnold, DH | 1 |
| Bloomberg, GR | 1 |
| Fukushima, Y | 1 |
| Kamiya, K | 1 |
| Tatewaki, M | 1 |
| Fukushima, F | 1 |
| Hirata, H | 1 |
| Ishii, Y | 1 |
| Fukuda, T | 1 |
| Truong, MT | 1 |
| Chang, KW | 1 |
| Berk, DR | 1 |
| Heerema-McKenney, A | 1 |
| Bruckner, AL | 1 |
| White, S | 1 |
| Keck, L | 1 |
| Meena, M | 1 |
| DeStephano, CC | 1 |
| Watson, WJ | 1 |
| Brost, BC | 1 |
| Söderlund-Venermo, M | 1 |
| Allander, T | 1 |
| Hedman, K | 1 |
| Zeiger, RS | 1 |
| Mauger, D | 1 |
| Guilbert, TW | 1 |
| Martinez, FD | 1 |
| Lemanske, RF | 1 |
| Strunk, RC | 1 |
| Covar, R | 1 |
| Szefler, SJ | 1 |
| Boehmer, S | 1 |
| Jackson, DJ | 1 |
| Sorkness, CA | 1 |
| Kelly, HW | 1 |
| Friedman, NJ | 1 |
| Mellon, MH | 1 |
| Schatz, M | 1 |
| Morgan, WJ | 1 |
| Chinchilli, VM | 1 |
| Raissy, HH | 1 |
| Bade, E | 1 |
| Malka-Rais, J | 1 |
| Taussig, LM | 1 |
| Lukkarinen, H | 1 |
| Khabie, N | 1 |
| Boyce, TG | 1 |
| Roberts, GD | 1 |
| Thompson, DM | 1 |
| Oommen, A | 1 |
| Ahrens, R | 1 |
| Lee, SY | 1 |
| Leung, CY | 1 |
| Leung, CW | 1 |
| Chow, CB | 1 |
| Leung, KM | 1 |
| Lee, QU | 1 |
| Parker, R | 1 |
| Powell, CV | 1 |
| Kelly, AM | 1 |
| Vanto, T | 4 |
| Hartiala, J | 3 |
| Mäkelä, MJ | 2 |
| Virkki, R | 1 |
| Leinonen, M | 1 |
| Peltola, V | 1 |
| Ruohola, A | 2 |
| Vuillermin, P | 1 |
| South, M | 3 |
| Robertson, C | 1 |
| Korppi, M | 1 |
| van Asperen, PP | 1 |
| Vuillermin, PJ | 2 |
| Robertson, CF | 2 |
| Carlin, JB | 1 |
| Biscan, MI | 1 |
| Brennan, SL | 1 |
| Hiekkanen, H | 2 |
| Malmberg, P | 1 |
| Mäkelä, M | 1 |
| Corcoran, BM | 1 |
| Foster, DJ | 1 |
| Fuentes, VL | 1 |
| Sasai, K | 1 |
| Yamabe, H | 1 |
| Haga, H | 1 |
| Tsutsui, K | 1 |
| Dodo, Y | 1 |
| Ishigaki, T | 1 |
| Shibamoto, Y | 1 |
| Abe, M | 1 |
| Fox, GF | 1 |
| Marsh, MJ | 1 |
| Milner, AD | 2 |
| Shindo, K | 1 |
| Machida, M | 1 |
| Fukumura, M | 1 |
| Koide, K | 1 |
| Cottin, V | 1 |
| Donsbeck, AV | 1 |
| Revel, D | 1 |
| Loire, R | 1 |
| Cordier, JF | 1 |
| Clement, F | 1 |
| van Woensel, JB | 1 |
| Kimpen, JL | 1 |
| Sprikkelman, AB | 1 |
| Ouwehand, A | 1 |
| van Aalderen, WM | 1 |
| Kitai, IC | 1 |
| Sanders, DM | 1 |
| Manungo, J | 1 |
| Webb, MS | 1 |
| Henry, RL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Viral Inception of Asthma: Prospective Study From Infancy to School-age.[NCT00731575] | 200 participants (Anticipated) | Interventional | 2007-06-30 | Active, not recruiting | |||
| CHildhood ASthma and Environment Research Study - CHASER Study[NCT02433275] | 1,600 participants (Anticipated) | Observational | 2011-09-30 | Recruiting | |||
| [NCT00494624] | Phase 4 | 300 participants (Anticipated) | Interventional | 2000-09-30 | Recruiting | ||
| AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED)[NCT04669288] | Phase 3 | 1,476 participants (Anticipated) | Interventional | 2021-09-22 | Recruiting | ||
| Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy, Safety and Tolerability of ORal Bacterial EXtract for the Prevention of Wheezing Lower Respiratory Tract Illness (ORBEX)[NCT02148796] | Phase 2 | 822 participants (Actual) | Interventional | 2017-01-03 | Active, not recruiting | ||
| Childhood Asthma Research and Education (CARE) Network Trial - Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)[NCT00675584] | Phase 3 | 278 participants (Actual) | Interventional | 2008-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00675584)
Timeframe: Measured during the 12-month follow-up period
| Intervention | Participants (Count of Participants) |
|---|---|
| Daily Budesonide | 3 |
| Intermittent Budesonide | 0 |
Exhaled nitric oxide (eNO) is measured in parts per billion, and the change constructed between 12 months and baseline (NCT00675584)
Timeframe: baseline and 12 months
| Intervention | parts per billion (Least Squares Mean) |
|---|---|
| Daily Budesonide | -0.14 |
| Intermittent Budesonide | -0.18 |
The caregiver quality-of-life questionnaire consists of seven questions, each scored from 0 (worse) to 3 (best), and all seven questions are summed to yield a total score ranging from 0 to 21 (NCT00675584)
Timeframe: baseline and 12 months
| Intervention | units on a scale (Least Squares Mean) |
|---|---|
| Daily Budesonide | 1.4 |
| Intermittent Budesonide | 2.0 |
Wheeze severity is scored as 0 (none) to 5 (very severe) during a respiratory tract illness (NCT00675584)
Timeframe: Measured during the first seven days for each respiratory tract illness
| Intervention | units on a scale (Mean) |
|---|---|
| Daily Budesonide | 0.5 |
| Intermittent Budesonide | 0.8 |
(NCT00675584)
Timeframe: Measured during the 12-month follow-up period
| Intervention | days per 12 months (Mean) |
|---|---|
| Daily Budesonide | 3.02 |
| Intermittent Budesonide | 2.72 |
"Treatment failure was defined as the occurrence of at least one of the following events:~four courses of systemic corticosteroids~one hospitalization for acute exacerbation of wheezing~hypoxic seizure during an acute exacerbation of asthma/wheezing~intubation for acute asthma/wheezing~serious adverse event related to a study medication~physician discretion with specific rationale" (NCT00675584)
Timeframe: Measured during the 12-month follow-up period
| Intervention | Participants (Count of Participants) |
|---|---|
| Daily Budesonide | 17 |
| Intermittent Budesonide | 9 |
(NCT00675584)
Timeframe: Measured during the 12-month follow-up period
| Intervention | visits per 12 months (Mean) |
|---|---|
| Daily Budesonide | 2.40 |
| Intermittent Budesonide | 2.37 |
(NCT00675584)
Timeframe: Measured during the 12-month follow-up period
| Intervention | proportion of days (Mean) |
|---|---|
| Daily Budesonide | 0.05 |
| Intermittent Budesonide | 0.06 |
An episode-free day consisted of no asthma symptoms and no asthma rescue medications (NCT00675584)
Timeframe: Measured during the 12-month follow-up period
| Intervention | proportion of episode-free days (Mean) |
|---|---|
| Daily Budesonide | 0.78 |
| Intermittent Budesonide | 0.78 |
The rate of exacerbations was calculated as the number of exacerbations requiring prednisone per years of follow-up (NCT00675584)
Timeframe: Measured during the 12-month follow-up period
| Intervention | events per years of follow-up (Mean) |
|---|---|
| Daily Budesonide | 0.97 |
| Intermittent Budesonide | 0.95 |
6 reviews available for prednisolone and Respiratory Sounds
| Article | Year |
|---|---|
Basic clinical management of preschool wheeze.
Topics: Child; Child, Preschool; Diagnosis, Differential; Humans; Leukotriene Antagonists; Prednisolone; Res | 2023 |
Managing wheeze in preschool children.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Asthma; Child, Preschool; Humans; Prednisolone; R | 2014 |
A child with difficulty swallowing.
Topics: Abscess; Child; Cranial Nerve Diseases; Deglutition Disorders; Diagnosis, Differential; Emergencies; | 2009 |
Recurrent wheezing illness in preschool-aged children: assessment and management in primary care practice.
Topics: Acetates; Administration, Inhalation; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; | 2009 |
Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children.
Topics: Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Glucocorticoids; Hospitalization; | 2006 |
Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children: systematic review.
Topics: Administration, Oral; Adolescent; Asthma; Child; Child, Preschool; Female; Glucocorticoids; Hospital | 2007 |
17 trials available for prednisolone and Respiratory Sounds
| Article | Year |
|---|---|
Itraconazole Improved Bronchial Wall Thickness in Severe Persistent Asthma: A Double-blind Placebo-controlled Randomized Clinical Trial.
Topics: Asthma; Bronchi; Double-Blind Method; Dyspnea; Forced Expiratory Volume; Humans; Itraconazole; Predn | 2023 |
Impact of oral corticosteroids on respiratory outcomes in acute preschool wheeze: a randomised clinical trial.
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Case-Control Studies; Child, Preschool | 2021 |
Efficacy of inhaled salbutamol with and without prednisolone for first acute rhinovirus-induced wheezing episode.
Topics: Acute Disease; Administration, Inhalation; Albuterol; Anti-Inflammatory Agents; Bronchodilator Agent | 2021 |
Efficacy of inhaled salbutamol with and without prednisolone for first acute rhinovirus-induced wheezing episode.
Topics: Acute Disease; Administration, Inhalation; Albuterol; Anti-Inflammatory Agents; Bronchodilator Agent | 2021 |
Efficacy of inhaled salbutamol with and without prednisolone for first acute rhinovirus-induced wheezing episode.
Topics: Acute Disease; Administration, Inhalation; Albuterol; Anti-Inflammatory Agents; Bronchodilator Agent | 2021 |
Efficacy of inhaled salbutamol with and without prednisolone for first acute rhinovirus-induced wheezing episode.
Topics: Acute Disease; Administration, Inhalation; Albuterol; Anti-Inflammatory Agents; Bronchodilator Agent | 2021 |
Prednisolone for the first rhinovirus-induced wheezing and 4-year asthma risk: A randomized trial.
Topics: Administration, Oral; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Child, Preschool; Dou | 2017 |
Oral prednisolone in preschool children with virus-associated wheeze: a prospective, randomised, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Australia; Child, Preschool; Double-Blind Method; Female; Glucocorticoids; Hum | 2018 |
Short- and long-term efficacy of prednisolone for first acute rhinovirus-induced wheezing episode.
Topics: Acute Disease; Anti-Inflammatory Agents; Double-Blind Method; Drug Administration Schedule; Female; | 2015 |
Oral prednisolone for preschool children with acute virus-induced wheezing.
Topics: Acute Disease; Administration, Oral; Albuterol; Bronchodilator Agents; Child; Child, Preschool; Doub | 2009 |
Daily or intermittent budesonide in preschool children with recurrent wheezing.
Topics: Administration, Inhalation; Administration, Oral; Asthma; Bronchodilator Agents; Budesonide; Child, | 2011 |
Daily or intermittent budesonide in preschool children with recurrent wheezing.
Topics: Administration, Inhalation; Administration, Oral; Asthma; Bronchodilator Agents; Budesonide; Child, | 2011 |
Daily or intermittent budesonide in preschool children with recurrent wheezing.
Topics: Administration, Inhalation; Administration, Oral; Asthma; Bronchodilator Agents; Budesonide; Child, | 2011 |
Daily or intermittent budesonide in preschool children with recurrent wheezing.
Topics: Administration, Inhalation; Administration, Oral; Asthma; Bronchodilator Agents; Budesonide; Child, | 2011 |
Prednisolone reduces recurrent wheezing after first rhinovirus wheeze: a 7-year follow-up.
Topics: Administration, Oral; Child; Child, Preschool; Female; Follow-Up Studies; Glucocorticoids; Humans; I | 2013 |
Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial.
Topics: Administration, Oral; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Asthma; Blood Proteins; Chi | 2003 |
Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema.
Topics: Child, Preschool; Cohort Studies; Eczema; Female; Follow-Up Studies; Humans; Infant; Male; Picornavi | 2007 |
Efficacy of prednisolone in children hospitalized for recurrent wheezing.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cough; Dyspnea; Enterovirus; Enterovi | 2007 |
Atopic characteristics of wheezing children and responses to prednisolone.
Topics: Administration, Oral; Adolescent; Antibodies, Viral; Breath Tests; Child; Child, Preschool; Diagnosi | 2007 |
Treatment of recurrent acute wheezing episodes in infancy with oral salbutamol and prednisolone.
Topics: Administration, Oral; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Drug Therapy, C | 1996 |
Prednisolone inhibits synthesis of 5-H(P)ETE in eosinophils from asthmatic patients during a wheezing attack but not during remission.
Topics: Adult; Arachidonic Acids; Asthma; Calcium; Cytosol; Dose-Response Relationship, Drug; Eosinophils; G | 1998 |
Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus.
Topics: Acute Disease; Anti-Inflammatory Agents; Bronchiolitis; Child, Preschool; Double-Blind Method; Femal | 2000 |
Oral corticosteroids for wheezing attacks under 18 months.
Topics: Age Factors; Asthma; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Infant; Infant, | 1986 |
36 other studies available for prednisolone and Respiratory Sounds
| Article | Year |
|---|---|
Prednisolone for the first rhinovirus induced wheezing reduces use of respiratory medication.
Topics: Enterovirus Infections; Humans; Infant; Picornaviridae Infections; Prednisolone; Respiratory Sounds; | 2022 |
Prednisolone for the first rhinovirus induced wheezing reduces use of respiratory medication.
Topics: Enterovirus Infections; Humans; Infant; Picornaviridae Infections; Prednisolone; Respiratory Sounds; | 2022 |
Prednisolone for the first rhinovirus induced wheezing reduces use of respiratory medication.
Topics: Enterovirus Infections; Humans; Infant; Picornaviridae Infections; Prednisolone; Respiratory Sounds; | 2022 |
Prednisolone for the first rhinovirus induced wheezing reduces use of respiratory medication.
Topics: Enterovirus Infections; Humans; Infant; Picornaviridae Infections; Prednisolone; Respiratory Sounds; | 2022 |
Reducing oral steroid intolerability and drug costs for acute wheezers: A retrospective evaluation of a clinical management algorithm in a Pediatric Emergency Department.
Topics: Asthma; Child; Dexamethasone; Drug Costs; Emergency Service, Hospital; Humans; Prednisolone; Respira | 2023 |
Rigid airway.
Topics: Antirheumatic Agents; Biopsy; Calcinosis; Cyclophosphamide; Diagnosis, Differential; Dyspnea; Female | 2020 |
Long-term control of laryngeal plasma cell mucositis with systemic immunosuppression.
Topics: Drug Administration Schedule; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; L | 2018 |
Oral corticosteroids in preschool children with severe episodes of virus-associated wheeze: To treat or not to treat?
Topics: Adrenal Cortex Hormones; Child, Preschool; Double-Blind Method; Humans; Prednisolone; Prospective St | 2018 |
Oral Dexamethasone to Control Wheezing in Children at an Outpatient Clinic.
Topics: Acute Disease; Administration, Oral; Ambulatory Care Facilities; Asthma; Child; Dexamethasone; Femal | 2019 |
Dexamethasone does not reduce length of hospitalization or recurrent wheezing 1 year after early bronchiolitis.
Topics: Bronchiolitis; Bronchodilator Agents; Dexamethasone; Disease Progression; Drug Therapy, Combination; | 2014 |
Prednisone for acute virus-associated wheeze in children: Panacea or one more brick in the wall?
Topics: Anti-Inflammatory Agents; Female; Humans; Male; Picornaviridae Infections; Prednisolone; Respiratory | 2015 |
Adjunct Systemic Corticosteroid Therapy in Children With Community-Acquired Pneumonia in the Outpatient Setting.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Asthma; Child; Child, Preschool; Dexamet | 2015 |
A really wheezy way to save money.
Topics: Adolescent; Asthma; Child; Child, Preschool; Female; Humans; Infant; Male; Prednisolone; Respiratory | 2016 |
What Is Your Diagnosis? Inflammatory granuloma.
Topics: Animals; Anorexia; Anti-Inflammatory Agents; Antinematodal Agents; Cat Diseases; Cats; Diagnosis, Di | 2016 |
Minimising wheeze in the under-threes: developing a respiratory assessment clinic for children.
Topics: Advanced Practice Nursing; Asthma; Child, Preschool; Cough; Glucocorticoids; Hospitalization; Humans | 2017 |
Practice imperfect--treatment for wheezing in preschoolers.
Topics: Administration, Inhalation; Administration, Oral; Androstadienes; Asthma; Bronchodilator Agents; Chi | 2009 |
Oral corticosteroids in children with wheezing.
Topics: Administration, Oral; Albuterol; Bronchodilator Agents; Child, Preschool; Glucocorticoids; Humans; P | 2009 |
Oral corticosteroids in children with wheezing.
Topics: Administration, Oral; Albuterol; Bronchodilator Agents; Child, Preschool; Glucocorticoids; Humans; P | 2009 |
Oral corticosteroids in children with wheezing.
Topics: Administration, Oral; Asthma; Bronchodilator Agents; Child, Preschool; Glucocorticoids; Humans; Pred | 2009 |
Oral corticosteroids in children with wheezing.
Topics: Administration, Oral; Child, Preschool; Drug Utilization; Glucocorticoids; Humans; Prednisolone; Res | 2009 |
A patient with bronchial asthma in whom eosinophilic bronchitis and bronchiolitis developed during treatment.
Topics: Androstadienes; Asthma; Bronchiolitis; Bronchitis; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cough | 2010 |
Propranolol for the treatment of a life-threatening subglottic and mediastinal infantile hemangioma.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Airway Obstruction; Antineoplastic Agents, Hormon | 2010 |
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: dexamethasone versus prednisolone in asthma.
Topics: Administration, Oral; Anti-Inflammatory Agents; Asthma; Child, Preschool; Dexamethasone; Emergency M | 2010 |
Shrinking lung syndrome in pregnancy complicated by antiphospholipid antibody syndrome.
Topics: Adult; Antiphospholipid Syndrome; Aspirin; Cesarean Section; Chest Pain; Dyspnea; Female; Heparin; H | 2011 |
No efficacy of prednisolone in acute wheezing associated with human bocavirus infection.
Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Female; Human bocavirus; Humans; Infant; Length o | 2011 |
Laryngeal sporotrichosis causing stridor in a young child.
Topics: Anti-Inflammatory Agents; Antifungal Agents; Female; Granuloma; Hoarseness; Humans; Infant; Laryngit | 2003 |
Oral prednisolone for viral wheeze in young children.
Topics: Administration, Oral; Anti-Inflammatory Agents; Asthma; Child, Preschool; Humans; Infant; Patient Se | 2004 |
Linear IgA bullous dermatosis in a neonate.
Topics: Glucocorticoids; Humans; Immunoglobulin A; Infant, Newborn; Mouth Mucosa; Prednisolone; Respiratory | 2004 |
How long does stridor at rest persist in croup after the administration of oral prednisolone?
Topics: Administration, Oral; Child; Child, Preschool; Croup; Emergencies; Glucocorticoids; Humans; Infant; | 2004 |
Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus.
Topics: Acute Disease; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Drug Admini | 2006 |
Bacterial coinfections in children with viral wheezing.
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Glucocorticoids; Hematologic Tests; Hospi | 2006 |
Are responses to treatment virus-specific in wheezing children?
Topics: Asthma; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Picornaviridae Infections | 2007 |
Oral corticosteroid therapy for acute asthma in children: evidence of efficacy and current Australian practice.
Topics: Acute Disease; Administration, Oral; Asthma; Australia; Child; Glucocorticoids; Humans; Parents; Pre | 2007 |
Parent-initiated oral corticosteroid therapy for acute asthma: a survey of current practice.
Topics: Administration, Oral; Asthma; Female; Glucocorticoids; Hospitalization; Humans; Male; Parents; Pract | 2007 |
Feline asthma syndrome: a retrospective study of the clinical presentation in 29 cats.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchi; Cat Diseases; Cats; Cough; Dyspnea; Female; Hype | 1995 |
Non-Hodgkin's lymphoma of the thyroid. A clinical study of twenty-two cases.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Anti | 1996 |
Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Biopsy; Connective Tissue Diseases; Cough; Dus | 1998 |
[Stridor caused by laryngeal rheumatoid arthritis].
Topics: Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Humans; Laryngeal Diseases; Male; Prednisolon | 1999 |
Tuberculosis presenting as corticosteroid responsive wheezing in infancy.
Topics: Asthma; Diagnosis, Differential; Humans; Infant; Prednisolone; Respiratory Sounds; Tuberculosis, Pul | 1989 |